English
Formulation and evaluation of Costus igneus herbal lollipops for diabetes management
Saidatri Arige
Lakshmana Rao A
Vinod Kumar V.L
Devika M
Veena Sree P P
Rama Krishna T.P
Abstract
Objectives: This study aims to develop and evaluate the efficacy of herbal lollipops incorporating Costus igneus extract for diabetes management. Materials and Methods: The powdered Costus igneus material was subjected to extraction using ethanol by Soxhlet extraction method. The extract was filtered and concentrated under reduced pressure to obtain a concentrated extract. Various formulations of herbal lollipops were prepared using different concentrations of Costus igneus extract, along with suitable excipients like stevia, binder and colors. Results: The formulated lollipops showed the uniformity in weight and thickness. The hardness of all formulated lollipops was found within the standard range up to 9.65 to 10.50 kg/cm2. From the in-vitro drug release study, it was found that the formulations of lollipops containing corn syrup in the concentrations of 100, 90 and 80 mg showed the maximum drug release at 30 minutes. Among those formulations formulation F9 showed 100.6% of drug release. The in-vitro release kinetic study of the optimized formulation (F9) was found to be first order. The release of the dosage form follows the diffusion and dissolution mechanism and Non-Fickian diffusion mechanism. Conclusion: These findings suggest that herbal lollipops containing Costus igneus hold promise as a novel and effective alternative for managing diabetes.
Keywords:
Costus igneus, Diabetes, Soxhlet extraction, herbal lollipopsSimilar Articles
- Paulina Oleksa, Daria Żuraw, Kacper Jasiński, Mateusz Sobczyk, Mikołaj Porzak, Alicja Sodolska, Karolina Haczkur-Pawłowska, Drugs and other chemical substances inducing diabetes – review of the literature , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Agnieszka Sienicka, Krzysztof Kubasik, Agata Pisula, The glucagon-like peptide-1 analogues therapy in the non-diabetic patients , Prospects in Pharmaceutical Sciences: Vol. 21 No. 1 (2023)
- Anna Machowska, OPTIMIZATION OF CADMIUM (II) RECOVERY IN SOLID PHASE EXTRACTION PROCESS WITH ION-IMPRINTED POLYMER AS THE SORBENT , Prospects in Pharmaceutical Sciences: Vol. 12 No. 2 (2014)
- Mateusz Kawka, Maciej Pilarek, Katarzyna Sykłowska-Baranek, Agnieszka Pietrosiuk, IN SITU EXTRACTION OF PLANT SECONDARY METABOLITES , Prospects in Pharmaceutical Sciences: Vol. 15 No. 7 (2017)
- Jakub Olszewski, Katarzyn Kozon, Andrzej Patyra, Flozins in heart failure – a new reimbursement indication , Prospects in Pharmaceutical Sciences: Vol. 20 No. 1 (2022)
- Mateusz Sobczyk, Daria Żuraw, Paulina Oleksa, Kacper Jasiński, Mikołaj Porzak, Michał Dacka, SGLT2 inhibitors and their possible use in prevention and treatment of neurological diseases , Prospects in Pharmaceutical Sciences: Vol. 22 No. 1 (2024)
- Wojciech Kaźmierski, Jakub Jurek, Paulina Lis, Anna Lis, Anna Ziobro, Mateusz Ziomek, Katarzyna Camlet, Kinga Kocur, Sodium-glucose cotransporter2 inhibitors in heart failure , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
- Maciej Bara, Jakub Starownik, Jakub Szydło, Patryk Gryszkiewicz, Jakub Nieznański, Dapagliflozin - new solution in chronic kidney disease treatment , Prospects in Pharmaceutical Sciences: Vol. 22 No. 2 (2024)
- Deepak Jha, Ashish Singh Pari, Phytochemical profile and physicochemical characterization of the leaves of Bauhinia racemosa , Prospects in Pharmaceutical Sciences: Vol. 23 No. 1 (2025)
- Saffalya Nayak, Pratima Kumari Sahu, Roma Rattan, Srikrushna Mahapatra, Debjyoti Mohapatra, Irisin levels in type 2 diabetes mellitus with and without non-alcoholic fatty liver disease: a case-control study , Prospects in Pharmaceutical Sciences: Vol. 22 No. 3 (2024)
You may also start an advanced similarity search for this article.
Details
References
Statistics
Authors
Citation rules
Cited by / Share
Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.